skip to Main Content

News

Latest News, Announcements, and Press Releases

14May 13

Codexis to Present at 2013 UBS Global Healthcare Conference

REDWOOD CITY, Calif.–(BUSINESS WIRE)–May. 14, 2013– Codexis, Inc. (NASDAQ: CDXS), a developer of engineered enzymes for pharmaceutical, biofuel and chemical production, today announced that John Nicols, President and CEO of Codexis, will present a company overview at the…
read more
07May 13

Codexis Reports First Quarter 2013 Results

— Product gross margin increases to 38%; Product revenue up 34% from fourth quarter 2012 — — Conference call today at 4:30 pm ET — REDWOOD CITY, Calif.–(BUSINESS WIRE)–May. 7, 2013– Codexis, Inc. (NASDAQ: CDXS), a developer of…
read more
22Apr 13

Codexis to Present at 2013 BIO International Convention

REDWOOD CITY, Calif.–(BUSINESS WIRE)–Apr. 22, 2013– Codexis, Inc. (NASDAQ: CDXS), a developer of engineered enzymes for pharmaceutical, biofuel and chemical production, announced today that Gjalt Huisman, Ph.D., Vice President, Pharmaceutical R&D at Codexis, will present at the 2013…
read more
27Feb 13

Codexis Reports Fourth Quarter and Full Year 2012 Results

— Conference call today at 4:30 pm ET — REDWOOD CITY, Calif.–(BUSINESS WIRE)–Feb. 27, 2013– Codexis, Inc. (NASDAQ: CDXS), a developer of engineered enzymes for pharmaceutical, biofuel and chemical production, today announced financial results for the fourth quarter…
read more

Since 2002, Codexis has created new technologies to unlock the power of proteins. Put our unmatched protein engineering expertise to work for you.

Unlock the power of proteins with Codexis

Back To Top
Close search
Search